Clinical trial
A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe…
NCT00385047 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00385047 |
|---|---|
| Title | A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults |
| Official title | Phase I/IIa Study of the Safety, Immunogenicity and Preliminary Efficacy After Sporozoite Challenge of FMP2.1/AS01B and FMP2.1/AS02A Candidate Malaria Vaccines Administered Intramuscularly at Months 0, 1, and 2 in Malaria-naive Adults Living in the United States |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | The PATH Malaria Vaccine Initiative (MVI) GlaxoSmithKline Industry United States Agency for International Development (USAID) U.S. Fed |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Biological |
| Interventions | Group A FMP2.1/AS01B, Group B FMP2.1/AS02A |
| Enrollment | 41 |
| Start date | Sep 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Oct 6, 2006 |
| Last update posted | Jun 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: